Biochemical and pharmacologic properties of L-asparaginase bonded to dacron vascular prostheses.
D000818:Animals; D000917:Antibody Formation; D000918:Antibody Specificity; D001215:Asparaginase / Q000037:antagonists & inhibitors / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use; D001216:Asparagine; D001391:Azo Compounds / Q000494:pharmacology; D001807:Blood Vessel Prosthesis; D004285:Dogs; D004926:Escherichia coli / Q000201:enzymology; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007700:Kinetics; D007942:Leukemia, Experimental / Q000188:drug therapy; D051379:Mice; D008811:Mice, Inbred DBA; D009994:Osmolar Concentration; D011093:Polyethylene Terephthalates; D011402:Pronase / Q000494:pharmacology; D011485:Protein Binding; D013237:Stereoisomerism; D013696:Temperature; D014633:Valine / Q000032:analysis / Q000494:pharmacology
D001391:Azo Compounds; D011093:Polyethylene Terephthalates; D001216:Asparagine; D011402:Pronase; D001215:Asparaginase; D014633:Valine